MedTrace Logo

Comparative Effects of Muscle Energy Technique and Modified Active Release Technique in Scapulocostal Syndrome.

NCT07403227 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-02-11

No results posted yet for this study

Summary

The study was conducted to determine the comparative effects of Muscle Energy Technique and Modified Active Release Technique on Pain, Chest expansion and Functional disability in patients with Scapulocostal Syndrome.

Conditions

  • Scapulocostal Syndrome

Interventions

OTHER

Muscle Energy Technique

Muscle Energy Technique (PIR) began by putting the muscles in stretched position. An isometric contraction was exerted against minimum resistance. Followed by Relaxation, then gentle stretch followed as the muscle releases. Tight, tender muscles commonly suffering with pain undergoes such techniques. All the contraction were hold for 10 seconds for each muscle i.e. 10 repetitions followed with 20 seconds rest time. 1. MET for upper Trapezius Muscle. 2. MET for Levator scapulae Muscle 3. MET for Rhomboid muscle

OTHER

Modified Active Release Technique

Modified Active Release Technique combined the active movement by patients with the passive movements done by the therapist. During this, participants were instructed to hold every movement for 6seconds with 10 repetitions. Pin and stretch type of modified active release technique was used in the study. 1. Modified Active Release Technique for Upper trapezius: 2. Modified Active Release Technique for Levator Scapulae: 3. Modified Active Release Technique for Rhombhoids.

OTHER

Conventional Physical Therapy

* Hot pack for 10 minutes. * Transcutaneous electrical nerve stimulation (TENS) (frequency: 2Hz and pulse duration 200 μs, 10 minutes

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Rafia Mannan, MS-SPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-10
Primary Completion
2025-07-28
Completion
2025-10-30

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07403227 on ClinicalTrials.gov